<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38381899</PMID><DateCompleted><Year>2024</Year><Month>02</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1678-9946</ISSN><JournalIssue CitedMedium="Internet"><Volume>66</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Revista do Instituto de Medicina Tropical de Sao Paulo</Title><ISOAbbreviation>Rev Inst Med Trop Sao Paulo</ISOAbbreviation></Journal><ArticleTitle>Cardiorespiratory optimal point in post-COVID-19 patients: a cross-sectional study.</ArticleTitle><Pagination><StartPage>e14</StartPage><MedlinePgn>e14</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e14</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1590/S1678-9946202466014</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0036-46652024000100602</ELocationID><Abstract><AbstractText>The varied clinical presentations of SARS-CoV-2 infection have raised concerns about long-term consequences, especially "long-COVID" or "post-COVID-19 syndrome." In this context, the cardiorespiratory optimal point (COP) within the Cardiopulmonary Exercise Test (CPET) emerges as a crucial metric for evaluating functional capacities and detecting cardiovascular and pulmonary anomalies post-COVID-19. This study aimed to assess COP values among post-COVID-19 patients and categorized them based on the initial severity of their disease. In this cross-sectional study conducted in the Northeast Brazil, 80 patients (26 females and 54 males) previously infected with SARS-CoV-2 underwent CPET. We clinically stratified patients into mild, moderate, or severe COVID-19 categories and assessed COP values and other cardiorespiratory metrics. We found differences in the predicted COP between patients with mild and severe COVID-19 (p=0.042). Additionally, patients with moderate and severe COVID-19 record had an average COP value exceeding 22. Other parameters, including respiratory exchange ratio, heart rate, and oxygen uptake efficiency slope, did not differ across the groups. Patients with a history of severe COVID-19 showed altered COP values, suggesting potential discrepancies in cardiovascular and respiratory system integration. The outcomes emphasize the importance of continuous monitoring and assessment of the cardiorespiratory domain for post-COVID-19 patients. Further research is needed to understand the relationship between elevated COP in post-severe COVID-19 and its long-term prognostic implications.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Santos</LastName><ForeName>Karinne Sim&#xf5;es da Cruz</ForeName><Initials>KSDC</Initials><AffiliationInfo><Affiliation>Universidade Tiradentes, Departamento de Medicina, Aracaju, Sergipe, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brito</LastName><ForeName>Gabriela Menezes Gon&#xe7;alves de</ForeName><Initials>GMG</Initials><AffiliationInfo><Affiliation>Universidade Tiradentes, Departamento de Medicina, Aracaju, Sergipe, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Melo</LastName><ForeName>Enaldo Vieira de</ForeName><Initials>EV</Initials><AffiliationInfo><Affiliation>Universidade Federal de Sergipe, Departamento de Medicina, Aracaju, Sergipe, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sousa</LastName><ForeName>Ant&#xf4;nio Carlos Sobral</ForeName><Initials>ACS</Initials><AffiliationInfo><Affiliation>Universidade Federal de Sergipe, Departamento de Medicina, Aracaju, Sergipe, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidade Federal de Sergipe, Programa de P&#xf3;s-Gradua&#xe7;&#xe3;o em Ci&#xea;ncias da Sa&#xfa;de, Aracaju, Sergipe, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rede D'Or S&#xe3;o Luiz, Cl&#xed;nica e Hospital S&#xe3;o Lucas, Aracaju, Sergipe, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidade Federal de Sergipe, Hospital Universit&#xe1;rio, Divis&#xe3;o de Cardiologia, Aracaju, Sergipe, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martins-Filho</LastName><ForeName>Paulo Ricardo</ForeName><Initials>PR</Initials><Identifier Source="ORCID">0000-0001-8779-0727</Identifier><AffiliationInfo><Affiliation>Universidade Federal de Sergipe, Programa de P&#xf3;s-Gradua&#xe7;&#xe3;o em Ci&#xea;ncias da Sa&#xfa;de, Aracaju, Sergipe, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidade Federal de Sergipe, Hospital Universit&#xe1;rio, Laborat&#xf3;rio de Patologia Investigativa, Aracaju, Sergipe, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campos</LastName><ForeName>Milena Dos Santos Barros</ForeName><Initials>MDSB</Initials><AffiliationInfo><Affiliation>Universidade Tiradentes, Departamento de Medicina, Aracaju, Sergipe, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidade Federal de Sergipe, Programa de P&#xf3;s-Gradua&#xe7;&#xe3;o em Ci&#xea;ncias da Sa&#xfa;de, Aracaju, Sergipe, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Rede D'Or S&#xe3;o Luiz, Cl&#xed;nica e Hospital S&#xe3;o Lucas, Aracaju, Sergipe, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Universidade Federal de Sergipe, Hospital Universit&#xe1;rio, Divis&#xe3;o de Cardiologia, Aracaju, Sergipe, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Brazil</Country><MedlineTA>Rev Inst Med Trop Sao Paulo</MedlineTA><NlmUniqueID>7507484</NlmUniqueID><ISSNLinking>0036-4665</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005080" MajorTopicYN="N">Exercise Test</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>CONFLICT OF INTERESTS. None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>21</Day><Hour>18</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>21</Day><Hour>14</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>2</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38381899</ArticleId><ArticleId IdType="pmc">PMC10881065</ArticleId><ArticleId IdType="doi">10.1590/S1678-9946202466014</ArticleId><ArticleId IdType="pii">S0036-46652024000100602</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Baggio JA, Exel AL, Calles AC, Minatel V. Severe Acute Respiratory Distress Syndrome (ARDS) caused by COVID-19: a regional factor. Arq Bras Cardiol. 2021;117:976&#x2013;977.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8682097</ArticleId><ArticleId IdType="pubmed">34817006</ArticleId></ArticleIdList></Reference><Reference><Citation>Skj&#xf8;rten I, Ankerstjerne OA, Trebinjac D, Br&#xf8;nstad E, Rasch-Halvorsen &#xd8;, Einvik G, et al. Cardiopulmonary exercise capacity and limitations 3 months after COVID-19 hospitalisation. 2100996Eur Respir J. 2021;58</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8247555</ArticleId><ArticleId IdType="pubmed">34210791</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Bowe B, Al-Aly Z. Burdens of post-acute sequelae of COVID-19 by severity of acute infection, demographics and health status. 6571Nat Commun. 2021;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8589966</ArticleId><ArticleId IdType="pubmed">34772922</ArticleId></ArticleIdList></Reference><Reference><Citation>Sociedade Brasileira de Cardiologia III Diretrizes da Sociedade Brasileira de Cardiologia sobre teste ergom&#xe9;trico. Arq Bras Cardiol. 2010;95(Suppl 1):1&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">21340292</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramos PS, Ricardo DR, Ara&#xfa;jo CG. Cardiorespiratory optimal point: a submaximal variable of the cardiopulmonary exercise testing. Arq Bras Cardiol. 2012;99:988&#x2013;996.</Citation><ArticleIdList><ArticleId IdType="pubmed">23033112</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramos PS, Ara&#xfa;jo CG. Cardiorespiratory optimal point during exercise testing as a predictor of all-cause mortality. Rev Port Cardiol. 2017;36:261&#x2013;269.</Citation><ArticleIdList><ArticleId IdType="pubmed">28318852</ArticleId></ArticleIdList></Reference><Reference><Citation>Ar&#xe9;valos V, Ortega-Paz L, Rodr&#xed;guez-Arias JJ, Calvo L&#xf3;pez M, Castrillo-Golvano L, Salazar-Rodr&#xed;guez A, et al. Acute and chronic fffects of COVID-19 on the cardiovascular system. 128J Cardiovasc Dev Dis. 2021;8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8541609</ArticleId><ArticleId IdType="pubmed">34677197</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomidokoro D, Hiroi Y. Cardiovascular implications of the COVID-19 pandemic. J Cardiol. 2022;79:460&#x2013;467.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8440165</ArticleId><ArticleId IdType="pubmed">34563439</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomerak S, Khan S, Almasri M, Hussein R, Abdelati A, Aly A, et al. Systemic inflammation in COVID&#x2010;19 patients may induce various types of venous and arterial thrombosis: a systematic review. Scand J Immunol. 2021;94</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8646950</ArticleId><ArticleId IdType="pubmed">34940978</ArticleId></ArticleIdList></Reference><Reference><Citation>Karim S, Islam A, Rafiq S, Laher I. The COVID-19 pandemic: disproportionate thrombotic tendency and management recommendations. 26Trop Med Infect Dis. 2021;6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7930939</ArticleId><ArticleId IdType="pubmed">33670475</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmid A, Petrovic M, Akella K, Pareddy A, Velavan SS. Getting to the heart of the matter: myocardial injury, coagulopathy, and other potential cardiovascular implications of COVID-19. Int J Vasc Med. 2021;2021:6693895.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8118745</ArticleId><ArticleId IdType="pubmed">34035963</ArticleId></ArticleIdList></Reference><Reference><Citation>AlRasheed MM, Al-Aqeel S, Aboheimed GI, AlRasheed NM, Abanmy NO, Alhamid GA, et al. Quality of life, fatigue, and physical symptoms post-COVID-19 condition: a cross-sectional comparative study. 1660Healthcare (Basel) 2023;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10252651</ArticleId><ArticleId IdType="pubmed">37297800</ArticleId></ArticleIdList></Reference><Reference><Citation>Brus IM, Spronk I, Haagsma JA, de Groot A, Tieleman P, Biere-Rafi S, et al. The prolonged impact of COVID-19 on symptoms, health-related quality of life, fatigue and mental well-being: a cross-sectional study. 1144707Front Epidemiol. 2023;3</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10911032</ArticleId><ArticleId IdType="pubmed">38455946</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliveira JF, &#xc1;vila RE, Oliveira NR, Sampaio NC, Botelho M, Gon&#xe7;alves FA, et al. Persistent symptoms, quality of life, and risk factors in long COVID: a cross-sectional study of hospitalized patients in Brazil. Int J Infect Dis. 2022;122:1044&#x2013;1051.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9330427</ArticleId><ArticleId IdType="pubmed">35908724</ArticleId></ArticleIdList></Reference><Reference><Citation>Debeaumont D, Boujibar F, Ferrand-Devouge E, Artaud-Macari E, Tamion F, Gravier FE, et al. Cardiopulmonary exercise testing to assess persistent symptoms at 6 months in people with COVID-19 who survived hospitalization: a pilot study. Phys Ther. 2021;101:pzab099.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7989156</ArticleId><ArticleId IdType="pubmed">33735374</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinaldo RF, Mondoni M, Parazzini EM, Pitari F, Brambilla E, Luraschi S, et al. Deconditioning as main mechanism of impaired exercise response in COVID-19 survivors. 2100870Eur Respir J. 2021;58</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8082950</ArticleId><ArticleId IdType="pubmed">33926969</ArticleId></ArticleIdList></Reference><Reference><Citation>Laukkanen JA, Kunutsor SK, Ara&#xfa;jo CG, Savonen K. Cardiorespiratory optimal point during exercise testing is related to cardiovascular and all-cause mortality. Scand J Med Sci Sports. 2021;31:1949&#x2013;1961.</Citation><ArticleIdList><ArticleId IdType="pubmed">34189765</ArticleId></ArticleIdList></Reference><Reference><Citation>Laukkanen JA, Savonen K, Hupin D, Ara&#xfa;jo CG, Kunutsor SK. Cardiorespiratory optimal point during exercise testing and sudden cardiac death: a prospective cohort study. Prog Cardiovasc Dis. 2021;68:12&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">34597617</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>